How do I tell dryness from an infection?
Vaginal dryness from genitourinary syndrome of menopause (GSM) often feels like friction, stinging on contact with urine, and soreness or spotting after sex—usually with little discharge. Infections like thrush or bacterial vaginosis tend to change discharge and smell, and itching can be intense. If symptoms keep returning after antifungals, think dryness or skin irritation. A clinician can examine, test and guide treatment. Educational only. Results vary. Not a cure.
Detailed Medical Explanation
Key differences at a glance. Dryness (part of GSM) typically brings reduced lubrication, a scratchy or sandpaper-like sensation with friction, stinging at the entrance, and sometimes post-coital spotting from micro-tears. Discharge is usually minimal and odour is typically unchanged. Infections more often alter discharge (colour, thickness, volume), add odour, and provoke intense itching or burning. Thrush usually gives thick, white, cottage-cheese-like discharge with marked itching; bacterial vaginosis can cause thin grey discharge with a fishy smell; UTIs cause burning when passing urine, urgency and frequency, often without vaginal discharge changes.
Why dryness happens. As oestrogen levels fall in peri- and post-menopause, the vaginal epithelium becomes thinner and less elastic, pH rises, and protective lactobacilli decline. This constellation—described as genitourinary syndrome of menopause (GSM)—increases friction sensitivity and vulnerability to superficial fissures. Pain can lead to pelvic floor guarding, making penetration sharper or burning even when you try to go slowly.
Why symptoms can be mixed. Dryness and infection sometimes overlap. GSM can raise vaginal pH and reduce lactobacilli, predisposing to infections in some people. Conversely, repeated self-treating presumed “”thrush”” can irritate already fragile tissue, keeping a cycle of soreness going. That’s why a clear assessment is helpful when symptoms persist.
Clues from your history. Patterns point to the cause: 1) Friction-linked flares (after sex, long walks, cycling, tampons), minimal discharge → dryness/GSM likely. 2) Marked itching + thick white discharge that settles with antifungals → thrush likely. 3) Fishy odour + thin grey discharge → consider BV. 4) Stinging during every wee with urgency/frequency → consider UTI (especially if urine dip or culture is positive). 5) White patches, tears, or architectural changes → consider dermatoses such as lichen sclerosus and seek review.
What you can try now. Adopt gentle vulval care (lukewarm water only; use a bland emollient as a soap substitute externally; avoid fragranced washes, wipes and bubble baths). Schedule a vaginal moisturiser several times weekly to rehydrate tissues; many prefer products that include hyaluronic acid. Keep a suitable personal lubricant for intimacy or examinations: water-based (versatile, condom-friendly), silicone-based (long-lasting glide), or oil-based (rich feel but may degrade latex condoms and some sex toys). If you’re weighing how care is structured, see our pages on common concerns we assess and how treatment steps are sequenced.
When to test or see someone. Arrange assessment if symptoms recur, are severe, or do not respond to sensible self-care; if you have new odour, unusual discharge, ulcers, fever, pelvic pain, visible blood in urine, or post-menopausal bleeding. A clinician may examine, check vaginal pH, take swabs (microscopy/culture), and exclude skin conditions. Targeted treatment—rather than guesswork—usually brings faster relief and avoids unnecessary medicines.
Trusted reading. For straightforward explanations of symptoms and when to seek help, see the NHS pages on vaginal thrush. Skin conditions that mimic infections (e.g., fissures, itching) are outlined by the British Association of Dermatologists.
Clinical Context
Who tends to confuse dryness with infection? Those in late perimenopause or post-menopause, especially after early menopause or oophorectomy, or when systemic HRT is unsuitable or declined. Sensitive skin, contact with fragranced products, tight sportswear, or high-friction activities (long-distance cycling) can amplify dryness-related stinging and itching. People who self-treat frequently with antifungals may see little benefit if the root cause is GSM, and the products themselves can irritate fragile skin.
Who should get assessed first? If you have severe itching, strong odour, thick clumpy discharge, fever, pelvic pain, visible haematuria, or new ulcers/white patches, arrange prompt review. Post-menopausal bleeding always needs assessment. Those with a history of hormone-sensitive cancer should discuss local oestrogen/DHEA with oncology and menopause teams to balance benefits and risks. Adjacent issues—pelvic floor over-activity, vestibulodynia, dermatitis and lichen sclerosus—often need specific management alongside dryness care.
Practical next steps: start with scheduled moisturiser use and the right lubricant, reduce irritants, allow unhurried arousal and try positions that reduce stretch at the entrance. Add local therapy (e.g., vaginal oestrogen or DHEA) if dryness persists despite basics. Plan a 6–12-week review to assess response and taper to the lowest effective maintenance. If cultures confirm infection, treat specifically and then revisit GSM care to reduce further irritation.
Evidence-Based Approaches
Guidelines recommend a step-wise pathway: offer information on vaginal moisturisers and lubricants, and consider low-dose local vaginal oestrogen for GSM when symptoms affect quality of life. See the NICE Menopause Guideline (NG23). Randomised trials synthesised by the Cochrane Library show that local oestrogens improve dryness, soreness, dyspareunia and pH versus placebo, with broadly similar efficacy across creams, tablets/pessaries and rings, and low systemic absorption at licensed doses.
For differential diagnosis and broader clinical framing of GSM and mimics, peer-reviewed reviews indexed on PubMed summarise mechanisms (thinner epithelium, higher pH, altered microbiome), conservative measures (moisturisers/lubricants), local hormonal options (oestrogen, DHEA), and when to consider pelvic floor and psychosexual approaches. Patient-facing symptom guidance is available from the NHS (e.g., thrush, BV, UTIs); choose one resource matched to your pattern rather than self-treating repeatedly without confirmation.
Skin conditions masquerading as infection—particularly lichen sclerosus—require targeted care and monitoring; see the British Association of Dermatologists for distinguishing features and next steps. In short, start with proven basics, escalate to local oestrogen if needed, and use tests to confirm infection rather than guessing—this reduces overtreatment and speeds relief.